Dipstick Leukocyturia as a Kidney Damage Biomarker in Rural Uganda and Kenya
Sahra Mohamed, Chi-Yuan Hsu, Edwin D. Charlebois, Jane Kabami, Mucunguzi Atukunda, James Ayieko, Gordon Orori, Matthew D. Hickey, Maya Petersen, Moses R. Kamya, Diane Havlir, Michelle M. Estrella, Anthony N. Muiru

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsNephrotoxicity and Medicinal Plants · Renal Diseases and Glomerulopathies · Chronic Kidney Disease and Diabetes
To the Editor:
The presence of sterile leukocyturia may provide diagnostic and prognostic insights into kidney health. For instance, leukocyturia among patients with chronic kidney disease (CKD) of unknown etiology is associated with lower estimated glomerular filtration rate, interstitial nephritis, and tubular atrophy on kidney biopsies.1 We previously reported a high prevalence of leukocyturia in sub-Saharan Africa.2 We now seek to better understand the risk factors associated with leukocyturia.
To estimate kidney disease prevalence in rural East Africa from 2016-2017, we measured serum creatinine and performed urine dipstick urinalysis.2 We interpreted dipstick urinalysis showing leukocyte esterase (≥1+) with nitrate negative results, as leukocyturia not explained by urinary tract infection. We included 3,462 community representative participants from Eastern Uganda, Southwestern Uganda, and Western Kenya.2 A detailed description of the study population and our sampling design can be found in the supplemental section (Item S1).
We applied weighted multivariable log-link Poisson regression models with robust standard errors to estimate the adjusted population-level prevalence ratios for leukocyturia and explored associations with risk factors including geographic region, serum creatinine, dipstick proteinuria, sociodemographic factors, smoking, alcohol, diabetes, hypertension, HIV, use of nonsteroidal anti-inflammatory drugs, and traditional herbal medicines. These factors were chosen based on their previous associations with kidney disease in sub-Saharan Africa and other regions.3, 4, 5, 6 We hypothesized that leukocyturia may indicate kidney damage.
We also evaluated whether certain environmental conditions, such as the mean surface air temperatures and high altitudes, were associated with leukocyturia and whether leukocyturia is associated with prevalent CKD (defined as an estimated glomerular filtration rate of <60 mL/min/1.73m^2^ or dipstick proteinuria ≥1+).
The baseline characteristics of the sampled participants and the weighted population-level estimates are shown in Table 1 and Table S1 respectively.Table 1. Baseline Characteristics of the Sampled ParticipantsNo Leukocyturia n = 3,163Leukocyturia n = 299TotalN = 3,462Region Eastern Uganda987 (31.2)164 (54.8)1,151 (33.2) Southwestern Uganda732 (23.1)98 (32.8)830 (24.0) Western Kenya1,444 (45.7)37 (12.4)1,481 (42.8)Sex Female2,025 (64.0)228 (76.3)2,253 (65.1) Male1,137 (36.0)71 (23.7)1,208 (34.9)Age categories 18-29 y613 (19.4)58 (19.4)671 (19.4) 30-44 y1,270 (40.1)97 (32.4)1,367 (39.5) 45-59 y800 (25.3)89 (29.8)889 (25.7) ≥60 y480 (15.2)55 (18.4)535 (15.4)Education level No formal education459 (14.8)82 (27.7)541 (15.9) Primary school2,174 (70.0)172 (58.1)2,346 (68.9) Secondary school and beyond474 (15.2)42 (14.2)516 (15.2)Wealth index/scorea 1st quintile587 (18.8)71 (24.0)658 (19.3) 2nd quintile517 (16.6)56 (18.9)573 (16.8) 3rd quintile630 (20.2)53 (17.9)683 (20.0) 4th quintile685 (22.0)67 (22.6)752 (22.0) 5th quintile698 (22.4)49 (16.6)747 (21.9)Farmer1,996 (64.2)231 (78.0)2,227 (65.4)Smoking status Never smoker2,714 (87.3)260 (87.5)2,974 (87.3) Current192 (6.2)17 (5.7)209 (6.1) Past203 (6.5)20 (6.7)223 (6.6)Any current alcohol use291 (10.1)34 (12.4)325 (10.3)CKDb240 (7.6)79 (26.7)319 (9.2)HIV-positive1,378 (44.2)143 (48.3)1,521 (44.6)Diabetes mellitus121 (3.9)13 (4.4)134 (3.9)Hypertension596 (19.3)56 (18.9)652 (19.2)Any NSAID use over the previous 90 days1,594 (51.3)128 (43.13)1,722 (50.5)Any traditional medicine use over the previous 90 days833 (26.8)89 (30.0)922 (27.1)Abbreviations: NSAID, nonsteroidal anti-inflammatory drugs; CKD, chronic kidney disease.aWealth index/score (divided in quintiles) was calculated using principal components analysis based on ownership of livestock and other household items.bDefined as serum creatinine estimated glomerular filtration rate of <60 mL/min/1.73m^2^ or proteinuria (urine dipstick ≥1+).
We observed a striking geographic variation in the prevalence of leukocyturia, with notably higher rates in Uganda (11.2% in Eastern and 8.7% in Southwestern Uganda) compared with 1.6% in Kenya.
In our fully adjusted model, residences in Eastern and Southwestern Uganda (compared with Kenya) were strongly associated with leukocyturia (adjusted prevalence ratio [aPR], 7.51; 95% confidence interval [CI], 4.36-12.95 and aPR, 7.78; 95% CI, 4.48-13.51). In addition, female sex (aPR, 1.80; 95% CI, 1.14-2.84), primary school education (aPR, 2.07; 95% CI, 1.04-4.12, compared with secondary school and beyond), and dipstick proteinuria (aPR, 3.58; 95% CI, 2.35-5.45) were associated with leukocyturia. We did not observe any significant associations between HIV, diabetes, or hypertension with leukocyturia (Table 2).Table 2. Unadjusted and Adjusted Association of Potential Risk Factors With LeukocyturiaLeukocyturiaUnadjusted Prevalence Ratio (95% CI)P ValueAdjusted Prevalence Ratio (95% CI)P ValueRegion Eastern Uganda7.20 (4.51-11.51)<0.0017.51 (4.36-12.95)a<0.001a Southwestern Uganda5.58 (3.34-9.33)<0.0017.78 (4.48-13.51)a<0.001a Western KenyaReferenceReferenceFemale2.22 (1.40-3.52)0.0011.80 (1.14-2.84)a0.01aAge 18-29 yReferenceReference 30-44 y0.68 (0.42-1.10)0.110.70 (0.44-1.12)0.14 45-59 y1.04 (0.65-1.68)0.861.00 (0.63-1.59)0.99 ≥60 y1.39 (0.86-2.24)0.181.43 (0.88-2.33)0.15Education level No formal education3.27 (1.62-6.60)0.0011.95 (0.95-3.99)0.07 Primary school1.73 (0.87-3.42)0.122.07 (1.04-4.12)a0.04a Secondary school and beyondReferenceReferenceWealth index 1st quintile (least wealth)ReferenceReference 2nd quintile (less wealth)1.04 (0.62-1.72)0.891.02 (0.63-1.67)0.91 3rd quintile (middle wealth)0.74 (0.41-1.32)0.300.98 (0.54-1.78)0.95 4th quintile (more wealth)0.96 (0.57-1.61)0.871.24 (0.76-2.03)0.39 5th quintile (most wealth)0.73 (0.41-1.32)0.301.05 (0.61-1.81)0.85Farmer1.93 (1.19-3.13)0.011.04 (0.67-1.60)0.86Smoking status Current smoker0.89 (0.47-1.69)0.730.95 (0.48-1.88)0.88 Past smoker0.88 (0.47-1.64)0.690.80 (0.43-1.49)0.48Any alcohol use0.68 (0.37-1.26)0.220.62 (0.32-1.20)0.16Dipstick proteinuria5.94 (4.08-8.65)<0.0013.58 (2.35-5.45)a<0.001aSerum creatinine0.32 (0.13-0.77)0.011.26 (0.78-2.06)0.35HIV-positive0.73 (0.55-0.98)0.041.14 (0.82-1.59)0.43Diabetes mellitus0.94 (0.44-1.99)0.870.69 (0.31-1.52)0.36Hypertension0.97 (0.64-1.48)0.900.70 (0.46-1.07)0.10Any NSAIDs use over the previous 90 days0.75 (0.52-1.09)0.131.12 (0.78-1.60)0.55Any traditional medicine use over the previous 90 days1.11 (0.77-1.60)0.570.86 (0.61-1.24)0.43Note: Adjusted model included geographic region, serum creatinine, dipstick proteinuria, sociodemographic factors, health habits (smoking and alcohol), diabetes, hypertension, HIV, proteinuria, hematuria, use of NSAIDs, and traditional herbal medicines.Abbreviations: CI, confidence interval; NSAID, nonsteroidal anti-inflammatory drugs.aSignificant values.
We found that the mean surface air temperatures in 2016 were 23.7 °C, 20.2 °C, and 22.1 °C, and the mean altitudes were 1,131 meters, 1,470 meters, and 1,397 meters in Eastern Uganda, Southwestern Uganda, and Kenya, respectively.7^,^8 However, neither the mean surface air temperatures nor altitudes were associated with leukocyturia (Table S2).
Leukocyturia was associated with CKD in the unadjusted (prevalence ratio, 4.81; 95% CI, 3.27-7.09) and fully adjusted models (aPR, 3.54; 95% CI, 2.20-5.68).
Given the patterns of leukocyturia in our study—highly variable geographic distribution between study communities and association with CKD—we postulate that leukocyturia may represent a marker of kidney damage in this region.
The observed geographical variations in leukocyturia distribution may suggest that these differences are attributed to environmental exposures. However, we could not verify this as neither mean surface air temperatures nor altitudes were found to be associated with leukocyturia.
Differences in leukocyturia prevalence have been noted among farm workers in various job categories, hinting at a potential influence from farming-related environmental factors.1 Despite a larger proportion of Eastern Uganda and Southwestern Uganda participants identifying as farmers compared with those in Western Kenya, farming occupation was not associated with leukocyturia in our study. Further investigations are needed to elucidate the role of environmental exposures in leukocyturia in this region.
Population-based studies on asymptomatic leukocyturia are scarce,9 and our report contributes to the literature by delineating patterns and risk factors for leukocyturia in rural East Africa. However, we acknowledge several limitations. We did not do urine cultures to rule out bacterial infection. We were unable to establish the relationship between leukocyturia and longitudinal loss of kidney function. Additionally, we did not conduct microscopic examinations of urine sediment, and relying solely on dipstick urinalysis limits our ability to make definitive links between our findings and clinically relevant kidney disease.
The absence of robust health care and research infrastructure in the region10 prevents us from making further connections between leukocyturia and advanced CKD (for example, kidney failure treated with dialysis). We lacked information on endemic infections such as tuberculosis, which might have provided additional insights into the etiology of leukocyturia. Nevertheless, the presence of leukocyturia in the context of infection can indicate genitourinary involvement and potentially contribute to subsequent kidney disease.
In conclusion, we observed that sterile leukocyturia has a striking geographic variation—being highly prevalent in rural Uganda but not in Kenya and is associated with CKD. Leukocyturia may represent a valuable marker of kidney damage in this region, and future studies should further characterize leukocyturia in these communities to determine its clinical significance.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Petropoulos Z.E.Laws R.L.Amador J.J.Kidney function, self-reported symptoms, and urine findings in Nicaraguan sugarcane workers Kidney 36011020201042105110.34067/KID.000339202035368783 PMC 8815494 · doi ↗ · pubmed ↗
- 2Muiru A.N.Charlebois E.D.Balzer L.B.The epidemiology of chronic kidney disease (CKD) in rural East Africa: a population-based study Plo S One 1532020 e 022964910.1371/journal.pone.0229649 PMC 705589832130245 · doi ↗ · pubmed ↗
- 3Kalyesubula R.Wearne N.Semitala F.C.Bowa K.HIV-associated renal and genitourinary comorbidities in Africa J Acquir Immune Defic Syndr 67suppl 12014 S 68S 7810.1097/QAI.000000000000025925117962 · doi ↗ · pubmed ↗
- 4Sandler D.P.Burr F.R.Weinberg C.R.Nonsteroidal anti-inflammatory drugs and the risk for chronic renal disease Ann Intern Med 1153199116517210.7326/0003-4819-115-3-1652058870 · doi ↗ · pubmed ↗
- 5Jha V.Herbal medicines and chronic kidney disease Nephrology (Carlton)15suppl 22010101710.1111/j.1440-1797.2010.01305.x 20586941 · doi ↗ · pubmed ↗
- 6Hsu C.Y.Iribarren C.Mc Culloch C.E.Darbinian J.Go A.S.Risk factors for end-stage renal disease: 25-year follow-up Arch Intern Med 1694200934235010.1001/archinternmed.2008.60519237717 PMC 2727643 · doi ↗ · pubmed ↗
- 7Topographic Maphttps://en-gb.topographic-map.com/
- 8The World Bank Climate change knowledge portalhttps://climateknowledgeportal.worldbank.org/
